A trial to study the patterns of thyroid dysfunction in pembrolizumab-induced painless thyroiditis
Latest Information Update: 03 Jun 2016
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 03 Jun 2016 New trial record
- 04 Apr 2016 Results presented at The 98th Annual Meeting of the Endocrine Society